The advertisement promotes Repatha® (evolocumab) for very high-risk ASCVD patients, emphasizing the need for treatment based on LDL-C levels and referencing safety information.
Creative Information
| CID: | fa4c7030-eb13-4172-9ed3-6b02d027b6c6 |
| CRID: | 89_188106 |
| Domain: | repatha.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $1.50 |
| Timestamp: | 11/13/2025, 3:26:45 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 1/4/2026, 2:34:23 AM | 4.66s | |
| adomain_analysis | success | 1/4/2026, 2:34:23 AM | 2.84s | |
| adomain_capture | success | 1/4/2026, 2:34:20 AM | 0.14s | |
| ad_render | success | 1/4/2026, 2:34:19 AM | 23.06s | |
| brand_mapping | success | 1/4/2026, 2:33:55 AM | 0.09s | |
Analysis Results
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1668.66 KB | ||||||||||||||||||||||
| Render Time: | 9.09 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | Domain:www.repatha.com Brand: | ||||||||||||||||||||||
| Total Ad Size: | 1730.66 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


